MedPath

Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study

Not Applicable
Not yet recruiting
Conditions
Colorectal Cancer
Pancreatic Cancer
Registration Number
NCT05400408
Lead Sponsor
Scentech Medical Technologies Ltd
Brief Summary

Detection of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study

Detailed Description

A diagnostic prospective study with no anticipated risks or constraints. Main Objective: To quantify differences in exhaled breath VOCs of patients with colorectal or pancreatic cancers compared with cohorts without cancer.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Age 18 to 85 years at the time of consent.
  • Scheduled for colonoscopy or Endoscopic Retrograde Cholangio Pancreatography.
  • Fasted >6 hours, consuming water only.
  • Able to provide informed written consent.
Exclusion Criteria
  • Lacks capacity or is unable to provide informed written consent.
  • Pregnant or lactating woman.
  • Histologically confirmed cancer in any organ.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
identification of Volatile Organic Compounds that can be related to Colorectal malignancy.Through the study completion, up to 1 year.

Comparison of identity and concentration of Volatile Organic Compounds profile found among colorectal patients and the identity and concentration of Volatile Organic Compounds profile found among Healthy controls.

Secondary Outcome Measures
NameTimeMethod
Test Sensitivity and specificity for colorectal polyps.Through the study completion, up to 1 year.

Comparison of Volatile Organic Compounds found among subjects with and without colorectal polyps.

Test Sensitivity and specificity for pancreatic cancer.Through the study completion, up to 1 year.

Comparison of Volatile Organic Compounds found among pancreatic patients and Healthy controls.

Trial Locations

Locations (1)

Shamir Medical Center

🇮🇱

Be'er Ya'aqov, Israel

Shamir Medical Center
🇮🇱Be'er Ya'aqov, Israel
Haim Shirin, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.